Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.

By D. Sibbing, S. Braun, T. Morath, J. Mehilli, W. Vogt, A. Schömig, A. Kastrati, N. von Beckerath. Journal of the American College of Cardiology, 2009

669 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Hematology

View Paper: https://www.semanticscholar.org/paper/159e40275cb89bc17bd31f4ed235af68916ef8d7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. L. Bonello
2. U. Tantry
3. N. Breet
4. M. Price
5. Deepak L. Bhatt
6. R. Marcucci
7. D. Angiolillo
8. R. Blindt

Citations in the corpus

• Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. (2010, methodology): “(80) demonstrated that high onreatment ADP-induced platelet reactivity measured before CI was associated with the occurrence of 30-day stent hrombosis in 1,608 patients who had received a 600-mg lopidogrel loading dose before PCI.”
• Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. (2010, background): “The greater importance of high on-treatment platelet reactivity in patients at higher risk has been demonstrated by Marcucci et al and Sibbing and et al.(7,9) Figure 1.”